possibility of tumor cells entering the blood flow, thus causing metastasis in distant organs. 6-8 A relationship between high MVD and increased risk of tumor recurrence and metastasis has been reported in breast cancer, 9,1° non-small-cell lung carcinoma, 11 and melanoma. t2 The results of a number of investigations on colorectal cancer have shown that there is a strong correlation between high MVD and the presence of lymph node or distant metastases, t3 t6 Very few studies have addressed the issue of the predictive value of MVD in lymph node-negative (LNN) colorectal cancer: the resuits have not been conclusive. ~7-19 To our knowledge, the possible prognostic role of MVD in LNN rectal cancer has not been reported.
The 
METHODS Patients
Between 1989 and 1996, 170 consecutive patients underwent radical surgical resection of rectal tumors (located no farther than 15 cm from the anal verge) at the Department of General Surgery, University of Florence (Italy). Eighty-four patients were included in the study: 60 (71.4%) were men, and 24 (28.6%) were women (median age, 65 years; range, 37-83 years). All subjects had tumors classified as T2 and T3 without lymph node or distant metastases (AJCC/UICC stage I and II, Dukes A and B). A retrospective study was performed on the clinical outcome of these patients. All surviving patients had been thoroughly informed about the study and gave written consent for the investigation in accordance with the ethical guidelines of our university. All patients were operated on by the same surgeon (C.C.). This most likely eliminated any surgeon-related prognostic factors that could have interfered with survival analysis, z° Operations were defined as radical when there had been no evidence of distant metastases or incomplete macroscopic clearance of the tumor and the pathologist reported tumor-free margins of the specimen. Complete circumferential excision of the mesorectum was performed in all patients with extraperitoneal carcinoma (middle and lower rectum); a distal clearance of at least 2 cm of healthy mucosa from the lower edge of the tumor was provided in all the patients who had undergone sphincter-saving operations. No patient received pre-or postoperative radiotherapy or chemotherapy. The median duration of follow-up for surviving patients was 67 months (range, 50-110 months).
Histopathological Staging
All surgical specimens were fixed in 10% formalin solution and routinely processed for paraffin embedding. We evaluated the following histopathological parameters for each tumor specimen: tumor type, classified into adenocarcinoma and mucinous carcinoma when more than 50% of the tumor volume was composed of mucin; tumor differentiation, classified as well differentiated, moderately differentiated, and poorly differentiated, according to the World Health Organization criteria2a; the depth of invasion of the tumors, classified as T2 (invasion of the muscularis propria) or T3 (invasion into the subserosa or into nonperitonealized perirectal tissues through the muscularis propria) according to the AJCC/ UICC cancer staging system22; extramural venous invasion, assessed according to the method described by Talbot et a1.23; the character of the invasive margin (expanding or infiltrating) and lymphocytic infiltration (conspicuous or little/absent), assessed according to criteria defined by Jass et al. z4 The median number of lymph nodes recovered and examined in the surgical specimens was 12 (range, 2-42).
Microvessel Immunohistochemical Staining
A monoclonal antibody against the endothelial antigen CD31 was used to stain the microvessels. Four-micrometer-thick sections were cut from formalin-fixed and paraffin-embedded tumor tissue blocks. They were mounted on poly-L-lysine-coated slides, dewaxed in xylene, and rehydrated through a graded series of ethanol. After deparaffinization, the sections were treated with 3% hydrogen peroxide in methanol solution for 20 minutes to block endogenous peroxidase activity. Sections were pretreated with protease type XIV (Sigma Chemical Co., St Louis, MO) in phosphate-buffered saline for 7 minutes at 37°C and then at 4°C for 5 minutes to quench enzymatic digestion. After incubating with normal rabbit serum for 5 minutes at room temperature, the slides were incubated with CD31 monoclonal antibody (JC 70TM; Dako, Milano, Italy), diluted 1/10, for 30 minutes at room temperature: this was followed by three washes with phosphate-buffered saline. The streptavidin-biotin method was used, with diaminobenzidine tetrahydrochloride as the chromogen. Sections were rinsed in deionized water, counterstained with Mayer's hematoxylin, and then dehydrated and mounted with Permount TM (Fisher Scientific, Fair Lawn, NJ). For negative controls, we used a nonspecific immunoglobulin G (normal rabbit immunoglobulin G) instead of primary antibody.
Microvessel Counting
One section per tumor was analyzed. MVD was evaluated by the same pathologist (A.P.) and reviewed by one observer (L.M.). Neither pathologist had any knowledge of the clinical outcome. The entire tumor section was first carefully scanned at low magnification (× 100) to find the areas that showed the most intense neovascularization (hot spots). These hot spots were identified as areas with the highest density of brown stained CD31 + cells. The microvessels that were included in the MVD counts were only those that had been in the stroma surrounded by malignant glands; the microvessels that had been found within areas of granulation tissue, such those near the surface of ulcerated tumors, were excluded from MVD counts. Individual microvessels in the hot
spots were then counted in a single ×250 field. Any immunoreactive endothelial cell or endothelial cell cluster that was clearly separated from the adjacent microvessels was considered as a single countable vessel. No vessel lumens or red blood cells were used to define a microvessel. The occasionally found immunoreactive lymphocytes, macrophages, and plasma cells were excluded on the basis of the staining pattern and cell morphology. MVD in each tumor was expressed as the microvessel count of the hot spot with the highest number of microvessels according to the methods proposed by Weidner. ~o
Statistical A n a l y s i s
Correlation between the microvessel count in the hot spot with the highest MVD and the microvessel count in the hot spot with the second highest MVD within the same tumor section was analyzed with Spearman's rank test. The relationships between MVD and the other clinicopathological variables were examined with the X 2 test. The relationship between clinicopathological variables and survival was estimated with the Kaplan-Meier method. z5 The Cox proportional hazards regression model e6 was used to identify those clinicopathological factors that independently influenced survival. For all the analyses, Stata Statistical Software T M release 6.0 (Stata Corp., College Station, TX) was used. A P value of .05 or less was considered significant.
R E S U L T S P a t i e n t O u t c o m e a n d C l i n i c o p a t h o l o g i c a l V a r i a b l e s
Thirty-five (41.7%) of the 84 patients had T2 tumors, and 49 (58.3%) had T3 tumors. Seventy-eight tumors (92.9%) were classified as adenocarcinomas and six (7.1%) as mucinous carcinomas. Seventeen adenocarcinomas (21.8%) were well differentiated, and 61 (78.2%) were moderately differentiated. No tumor was classified as poorly differentiated. Tumor invasion of the extramural veins was present in 14 (16.7%) patients; it was absent in 70 (83.3%). Forty-six (54.8%) tumors were classified as having an expanding invasive margin and 38 (45.2%) as having an infiltrating one. Lymphocytic infiltration was conspicuous in 16 patients (19.0%); it was little or absent in 68 (81.0%).
In each tumor section, the microvessel count of the hot spot with the highest MVD significantly correlated with the microvessel count of the hot spot with second highest vessel density (r = .74, P < .0001; Fig. 1 ). The median MVD of all the patients was 45 (range, 18-153). This cutoff was used to identify two groups of patients. Low MVD (-<45) was found in 41 patients (48.8%), and high Figure  2A and B shows representative cases with low and high MVD, respectively. A highly significant association was found between tumors with high MVD and those with conspicuous lymphocytic infiltration (P = .001; Table  1 ). Figure 3 shows a representative tumor sample with conspicuous lymphocytic infiltration and high MVD. No significant association was found between MVD and the other clinicopathological features.
Prognosis
Sixty-five of the 84 patients were alive at the time of the last follow-up: none showed any evidence of the disease. Nineteen patients had died of disease relapse. Nine patients (10.7%) had distant metastases, six patients (7.1%) had local recurrence, and four patients (4.7%) had both distant metastases and local recurrence. The overall rate of tumor relapse in our study was comparable to that reported by other authors who did not perform pre-or postoperative adjuvant therapy. 27-29 In univariate analysis, the depth of local invasion and the character of the invasive margin were significantly related to survival ( 
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hazards model. Only the character of the invasive margin emerged as an independent prognostic factor ( Table 3 ).
DISCUSSION
The relationship between quantitative assessment of angiogenesis, assessed as MVD, and prognosis has been studied in many types of tumors, including colorectal cancer. 13-~6 Most of these studies have shown that a high density of microvessels is associated with short-term survival and thus can be considered a marker of tumor aggressiveness.
The need for new prognostic factors is particularly urgent for LNN colorectal cancer patients. In fact, this group of patients is still a broad category with respect to clinical outcome. It is of critical importance that additional prognostic information be available to better identify those patients who are likely to experience tumor relapse. As a consequence, they could receive the most benefit from adjuvant therapy. There is as yet no consensus regarding the prognostic value of MVD in earlystage colorectal cancer. In two published studies on LNN colon cancer, 17,Is prognosis was significantly better in the low-MVD patient groups than in those with high MVD. These results were not confirmed when tumors of the colon and of the rectum were analyzed together. Banner et al. t9 reported contrasting results: microvessel counts in stage II colorectal cancer subjects were higher in their long-term survival patient group than in their short-term one. To our knowledge, this study is the first to address the question of the prognostic importance of angiogenesis in LNN rectal cancer. The purpose of this study was to evaluate whether the predictive value of MVD could compete successfully with the prognostic importance of the well-known histopathological parameters in rectal cancer, such those used in the Dukes and Jass colorectal cancer staging classifications. We found that both the depth of local invasion and the character of the invasive margin were significant predictors of survival in univariate analysis. However, only the character of the invasive margin emerged as an independent prognostic factor from multivariate analysis. Tumor type and differentiation, venous invasion, lymphocytic infiltration, and MVD failed to show any relevance in predicting survival.
We found a significant correlation between the degree of lymphocytic infiltration and MVD: tumors with conspicuous lymphocytic infiltration were more frequent in the high-MVD group than in the low-MVD one. Our data are consistent with findings reported by Giatromanolaki et al. 3° They found a striking association between CD31 + lymphocyte infiltration and high vascular density. Moreover, they did not find any correlation between microvessel count and prognosis in their Dukes B patients. A similar association was reported in patients with non-small-cell lung carcinoma 31 and in those with renal tumors. 32 These findings are not surprising. A number of recent studies have demonstrated that the inflammatory cell infiltrate significantly contributes to the angiogenic process in malignant disease. 33-3~ As regards colorectal cancer, it has been demonstrated that PD-ECGF is mainly expressed by tumor-infiltrating macrophages and lymphocytes. Thus, PD-ECGF is considered one of the most important promoters of the angiogenic pathway associated with the immune response against cancer. 36, 37 All these data, when taken together, may provide an explanation for our results. Jass 38 has demonstrated that conspicuous lymphocytic infiltration is more frequently associated with early-stage rectal tumors than with those with lymph node or distant metastases. This infiltration has been considered the expression of an effective cellmediated immune response against the tumor. The activity of the immune cells has also been associated with the production of angiogenic promoters and, thus, with stimulation of tumor vascularity. 33-37 As a consequence, the favorable prognostic effect of the host immunological reaction to invading rectal carcinoma, i.e., the presence of conspicuous lymphocytic infiltration, might interfere MVD, microvessel density.
with the negative effect of a large vascular surface area within the tumor. The result would be a lack of any significant prognostic significance regarding either MVD or the degree of lymphocytic infiltration. This hypothesis may explain our results in LNN rectal cancer patients. Failure of capacity of the degree of lymphocytic infiltration to be a significant prognostic factor has been the experience of other investigators. 39-41 This finding has been explained by poor interobserver and intraobserver reproducibility as regards this histopathological parameter. However, none of the studies mentioned 39-41 ever noted or even suggested that there could be any association between the immune response and the promotion of the angiogenic process as an explanation for their results.
Another hypothesis that may explain our findings was put forth by Giatromanolaki et al. 3° They suggested the presence of specific angiogenic profiles that may differ substantially with regard to tumor relapse; i.e., the angiogenic pathway associated with the immune response may not be associated with aggressive tumor behavior. This hypothesis has been given further support by recently reported data on a significant association between the expression of PD-ECGF and a good prognosis in colorectal cancer. 37 It has been suggested 42 that the discrepancy in results regarding the prognostic value of microvessel count might be related to some differences in methodology. The choice of the endothelial antibodies for immunohistochemical staining and the selection of the area for microvessel quantification have been among the variables cited. In our study, a monoclonal antibody against CD31 was used to highlight the endothelial cells, and the microvessels were counted in the areas that showed the highest degree of vessel density (hot spots), as suggested by a recent international consensus on the methodology and criteria of angiogenesis quantification. 42 Another issue that should be addressed is the possible heterogeneity of tumor vascularity within each histopathological section. We found that the microvessel count of the hot spot with the highest MVD significantly correlated with the microvessel count of the hot spot with the second highest MVD. This finding supports the hypothesis that the degree of vascularization in different hot spots may be similar within the same colorectal tumor section and thus might represent a biological feature of a single tumor, as previously suggested by Vermeulen et al. 43 In conclusion, MVD does not seem to provide any additional prognostic information when compared with standard histopathological variables in patients with LNN rectal cancer. The frequent presence of conspicuous lymphocytic infiltration in early-stage rectal cancer and the effective role of the immune cells in promoting the angiogenic process may interfere with the effectiveness of MVD in predicting the clinical outcome in this group of patients.
